Skip to main content
SpringerLink
Log in
Book cover

Pancreatic Disease pp 121–131Cite as

Treatment of Exocrine Pancreatic Insufficiency in Chronic Pancreatitis

  • Chapter

  • 87 Accesses

Abstract

The treatment of exocrine pancreatic insufficiency has come a long way. Presently, many patients can be treated satisfactorily with high-strength (≥20,000 Ph.Eur.U. [units of enzyme activity according to the European Pharmacopeia] of lipase per capsule) enteric-coated mini-dose-unit preparations. In some cases, however, treatment remains difficult and a true challenge to the clinician. Insight into the gastrointestinal (patho)physiology of exocrine pancreatic insufficiency and properties of the pharmaceutical preparations is prerequisite to the achievement of optimal treatment results.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. DiMagno EP, Layer P, Clain JE (1993) Chronic pancreatitis. In: Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA (eds) The pancreas: biology, pathobiology, and disease, 2nd edn. Raven, New York, pp 665–706

    Google Scholar 

  2. Dutta SK, Bustin MP, Russell RM, Costa BS (1982) Deficiency of fat-soluble vitamins in treated patients with pancreatic insufficiency. Ann Intern Med 97:549–552

    PubMed  CAS  Google Scholar 

  3. Montalto G, Soresi M, Carroccio A, et al (1994) Lipoproteins and chronic pancreatitis. Pancreas 9:137–138

    Article  PubMed  CAS  Google Scholar 

  4. Gullo L, Stella A, Labriola E, Costa PL, Descovich G, Labo G (1982) Cardiovascular lesions in chronic pancreatitis: a prospective study. Dig Dis Sci 27:716–722

    Article  PubMed  CAS  Google Scholar 

  5. Gullo L, Tassoni U, Mazzoni G, Stefanini F (1996) Increased prevalence of aortic calcification in chronic pancreatitis. Am J Gastroenterol 91:759–761

    PubMed  CAS  Google Scholar 

  6. Layer P, Go VL, DiMagno EP (1986) Fate of pancreatic enzymes during small intestinal aboral transit in humans. Am J Physiol 251:G475–G480

    PubMed  CAS  Google Scholar 

  7. DiMagno EP, Malagelada JR, Go VL, Moertel CG (1977) Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med 296:1318–1322

    Article  PubMed  CAS  Google Scholar 

  8. Heizer WD, Cleaveland CR, Iber FL (1965) Gastric inactivation of pancreatic supplements. Bull John Hopkins Hosp 116:261–270

    PubMed  CAS  Google Scholar 

  9. Thiruvengadam R, DiMagno EP (1988) Inactivation of human lipase by proteases. Am J Physiol 255:G476–G481

    PubMed  CAS  Google Scholar 

  10. Regan PT, Malagelada JR, DiMagno EP, Glanzman SL, Go VL (1977) Comparative effects of antacids, Cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 297:854–858

    Article  PubMed  CAS  Google Scholar 

  11. DiMagno EP, Go VL Summerskill WH (1973) Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 288:813–815

    Article  PubMed  CAS  Google Scholar 

  12. Bovo P, Cataudella G, Di Francesco V, et al (1995) Intraluminal gastric pH in chronic pancreatitis. Gut 36:294–298

    Article  PubMed  CAS  Google Scholar 

  13. Regan PT, Malagelada JR, DiMagno EP, Go VL (1979) Postprandial gastric function in pancreatic insufficiency. Gut 20:249–254

    Article  PubMed  CAS  Google Scholar 

  14. Dutta SK, Russell RM, Iber FL (1979) Impaired acid neutralization in the duodenum in pancreatic insufficiency. Dig Dis Sci 24:775–780

    Article  PubMed  CAS  Google Scholar 

  15. Dutta SK, Russell RM, Iber FL (1979) Influence of exocrine pancreatic insufficiency on the intraluminal pH of the proximal small intestine. Dig Dis Sci 24:529–534

    Article  PubMed  CAS  Google Scholar 

  16. Andersen JR, Bendtsen F, Ovesen L, Pedersen NT, Rune SJ, Tage-Jensen U (1990) Pancreatic insufficiency. Duodenal and jejunal pH, bile acid activity, and micellar lipid solubilization. Int J Pancreatol 6:263–270

    PubMed  CAS  Google Scholar 

  17. Zentler-Munro PL, Fitzpatrick WJ, Batten JC, Northfield TC (1984) Effect of intrajejunal acidity on aqueous phase bile acid and lipid concentrations in pancreatic steatorrhoea due to cystic fibrosis. Gut 25:500–507

    Article  PubMed  CAS  Google Scholar 

  18. DiMagno EP (1982) Controversies in the treatment of exocrine pancreatic insufficiency. Dig Dis Sci 27:481–484

    Article  PubMed  CAS  Google Scholar 

  19. Bruno MJ, Rauws EA, Hoek FJ, Tytgat GN (1994) Comparative effects of adjuvant Cimetidine and omeprazole during pancreatic enzyme replacement therapy. Dig Dis Sci 39:988–992

    Article  PubMed  CAS  Google Scholar 

  20. Graham DY (1979) An enteric-coated pancreatic enzyme preparation that works. Dig Dis Sci 24:906–909

    Article  PubMed  CAS  Google Scholar 

  21. Dutta SK, Tilley DK (1983) The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency. J Clin Gastroenterol 5:51–54

    Article  PubMed  CAS  Google Scholar 

  22. Schneider MU, Knoll-Ruzicka ML, Domschke S, Heptner G, Domschke W (1985) Pancreatic enzyme replacement therapy: comparative effects of conventional and entericcoated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis. Hepatogastroenterology 32:97–102

    PubMed  CAS  Google Scholar 

  23. Lankisch PG, Lembcke B, Goke B, Creutzfeldt W (1986) Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage? Z Gastroenterol 24:753–757

    PubMed  CAS  Google Scholar 

  24. Dutta SK, Rubin J, Harvey J (1983) Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroenterology 84:476–482

    PubMed  CAS  Google Scholar 

  25. Jorgensen BB, Pedersen NT, Worning H (1991) Monitoring the effect of substitution therapy in patients with exocrine pancreatic insufficiency. Scand J Gastroenterol 26:321–326

    Article  PubMed  CAS  Google Scholar 

  26. Delhaye M, Meuris S, Gohimont AC, Buedts K, Cremer M (1996) Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis. Eur J Gastroenterol Hepatol 8:699–703

    PubMed  CAS  Google Scholar 

  27. Lamers CB, Jansen JB (1986) Omeprazole as adjunct to enzyme replacement treatment in severe pancreatic insufficiency. Br Med J 293:994–994

    Article  CAS  Google Scholar 

  28. Youngberg CA, Bernardi RR, Howatt WF (1987) Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects. Dig Dis Sci 32:472–480

    Article  PubMed  CAS  Google Scholar 

  29. Meyer JH, Elashoff J, Porter-Fink V, Dressman J, Amidon GL (1988) Human postprandial gastric emptying of 1-to 3-millimeter spheres. Gastroenterology 94:1315–1325

    PubMed  CAS  Google Scholar 

  30. Mundlos S, Kuhnelt P, Adler G (1990) Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test. Gut 31:1324–1328

    Article  PubMed  CAS  Google Scholar 

  31. Kuhnelt P, Mundlos S, Adler G (1991) Effect of pellet size of a pancreas enzyme preparation on duodenal lipolytic activity. Z Gastroenterol 29:417–421

    PubMed  CAS  Google Scholar 

  32. Bruno MJ, Borm JJ, Hoek FJ, et al (1998) Gastric transit and pharmacodynamics of a two-millimeter enteric-coated pancreatin microsphere preparation in patients with chronic pancreatitis. Dig Dis Sci 43:203–213

    Article  PubMed  CAS  Google Scholar 

  33. Gottschalk B, Wiesemann HG, Stephan U (1988) Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis). Monatsschr Kinderheilkd 136:626–629

    PubMed  CAS  Google Scholar 

  34. Stern M, Plettner C, Gruttner R (1988) Pancreatic enzyme replacement in mucoviscidosis (CF): clinical evaluation of a gastric acid-resistant pancreatin preparation in encapsulated microtablet form. Klin Padiatr 200:36–39

    Article  PubMed  CAS  Google Scholar 

  35. Lankisch PG, Lembcke B, Kirchhoff S, Hilgers R, Creutzfeldt W (1988) Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations. Dtsch Med Wochenschr 113:15–17

    Article  PubMed  CAS  Google Scholar 

  36. Beverley DW, Kelleher J, MacDonald A, Littlewood JM, Robinson T, Walters MP (1987) Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child 62:564–568

    Article  PubMed  CAS  Google Scholar 

  37. Braggion C, Borgo G, Faggionato P, Mastella G (1987) Influence of antacid and formulation on effectiveness of pancreatic enzyme supplementation in cystic fibrosis. Arch Dis Child 62:349–356

    Article  PubMed  CAS  Google Scholar 

  38. Williams J, MacDonald A, Weller PH, Fields J, Pandov H (1990) Two enteric-coated microspheres in cystic fibrosis. Arch Dis Child 65:594–597

    Article  PubMed  CAS  Google Scholar 

  39. Thomson M, Clague A, Cleghorn GJ, Shepherd RW (1993) Comparative in vitro and in vivo studies of enteric-coated pancrelipase preparations for pancreatic insufficiency. J Pediatr Gastroenterol Nutr 17:407–413

    Article  PubMed  CAS  Google Scholar 

  40. Bruno MJ, Haverkort EB, Tytgat GN, van Leeuwen DJ (1995) Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment. Am J Gastroenterol 90:1383–1393

    PubMed  CAS  Google Scholar 

  41. Ramo OJ, Puolakkainen PA, Seppala K, Schroder TM (1989) Self-administration of enzyme substitution in the treatment of exocrine pancreatic insufficiency. Scand J Gastroenterol 24:688–692

    Article  PubMed  CAS  Google Scholar 

  42. Smyth RL, van Velzen D, Smyth AR, Lloyd DA, Heaf DP (1994) Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 343:85–86

    Article  PubMed  CAS  Google Scholar 

  43. FitzSimmons SC, Burkhart GA, Borowitz D, et al (1997) High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 336:1283–1289

    Article  PubMed  CAS  Google Scholar 

  44. Caliari S, Benini L, Sembenini C, Gregori B, Carnielli V, Vantini I (1996) Mediumchain triglyceride absorption in patients with pancreatic insufficiency. Scand J Gastroenterol 31:90–94

    Article  PubMed  CAS  Google Scholar 

  45. Russell RM, Dutta SK, Oaks EV, Rosenberg IH, Giovetti AC (1980) Impairment of folic acid absorption by oral pancreatic extracts. Dig Dis Sci 25:369–373

    Article  PubMed  CAS  Google Scholar 

  46. Glasbrenner B, Malfertheiner P, Büchler M, Kuhn K, Ditschuneit H (1991) Vitamin B12 and folic acid deficiency in chronic pancreatitis: a relevant disorder? Klin Wochenschr 69:168–172

    Article  PubMed  CAS  Google Scholar 

  47. Henderson JT, Simpson JD, Warwick RR, Shearman DJ (1972) Does malabsorption of vitamin B12 occur in chronic pancreatitis? Lancet 2:241–243

    Article  PubMed  CAS  Google Scholar 

  48. Leng-Peschlow E (1989) Interference of dietary fibres with gastrointestinal enzymes in vitro. Digestion 44:200–210

    Article  PubMed  CAS  Google Scholar 

  49. Dutta SK, Hlasko J (1985) Dietary fiber in pancreatic disease: effect of high fiber diet on fat malabsorption in pancreatic insufficiency and in vitro study of the interaction of dietary fiber with pancreatic enzymes. Am J Clin Nutr 41:517–525

    PubMed  CAS  Google Scholar 

  50. Regan PT, DiMagno EP (1980) Exocrine pancreatic insufficiency in celiac sprue: a cause of treatment failure. Gastroenterology 78:484–487

    PubMed  CAS  Google Scholar 

  51. Lembcke B, Kraus B, Lankisch PG (1985) Small intestinal function in chronic relapsing pancreatitis. Hepatogastroenterology 32:149–151

    PubMed  CAS  Google Scholar 

  52. Guarner L, Rodriguez R, Guarner F, Malagelada JR (1993) Fate of oral enzymes in pancreatic insufficiency. Gut 34:708–712

    Article  PubMed  CAS  Google Scholar 

  53. Gan KH, Geus WP, Bakker W, Lamers CB, Heijerman HG (1996) In vitro dissolution profiles of enteric-coated microsphere/microtablet pancreatin preparations at different pH values. Aliment Pharmacol Ther 10:771–775

    Article  PubMed  CAS  Google Scholar 

  54. Zentler-Munro PL, Assoufi BA, Balasubramanian K, et al (1992) Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhoea due to cystic fibrosis. Pancreas 7:311–319

    Article  PubMed  CAS  Google Scholar 

  55. Moreau J, Bouisson M, Saint MGM, Pignal F, Bommelaer G, Ribet A (1988) Comparison of fungal lipase and pancreatic lipase in exocrine pancreatic insufficiency in man. Study of their in vitro properties and intraduodenal bioavailability. Gastroenterol Clin Biol 12:787–792

    PubMed  CAS  Google Scholar 

  56. Raimondo M, DiMagno EP (1994) Lipolytic activity of bacterial lipase survives better than that of porcine lipase in human gastric and duodenal content. Gastroenterology 107:231–235

    PubMed  CAS  Google Scholar 

  57. Suzuki A, Mizumoto A, Sarr MG, DiMagno EP (1997) Bacterial lipase and high-fat diets in canine exocrine pancreatic insufficiency: a new therapy of steatorrhea? Gastroenterology 112:2048–2055

    Article  PubMed  CAS  Google Scholar 

  58. Maeda H, Danel C, Crystal RG (1994) Adenovirus-mediated transfer of human lipase complementary DNA to the gallbladder. Gastroenterology 106:1638–1644

    PubMed  CAS  Google Scholar 

  59. Ramakrishna J, Grand RJ (1994) Gene therapy for exocrine pancreatic insufficiency. Gastroenterology 106:1711–1713

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. M. J. Bruno
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bruno, M.J. (1999). Treatment of Exocrine Pancreatic Insufficiency in Chronic Pancreatitis. In: Pancreatic Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60068-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60068-5_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-65357-8

  • Online ISBN: 978-3-642-60068-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation